Compare Samcro Hyosung Adilestari Tbk. (ACRO) vs Bundamedik Tbk (BMHS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Samcro Hyosung Adilestari Tbk. vs Bundamedik Tbk — how do they compare? Samcro Hyosung Adilestari Tbk. trades at Rp63 (market cap 218.57B, 5.19M 24h volume), while Bundamedik Tbk trades at Rp188 (market cap 1.63T, 725.9K 24h volume). The key difference: Bundamedik Tbk is far larger — about 7.5× Samcro Hyosung Adilestari Tbk.'s market cap, and Samcro Hyosung Adilestari Tbk. is more actively traded (5.19M versus 725.9K). Which is the better fit depends on your goals.
| ACRO | BMHS | |
|---|---|---|
Market Cap | 218.57B | 1.63T |
Volume | 5.19M | 725.9K |
Lot | 51.94K | 7.26K |
Turnover | 327.46M | 135.94M |
Average Price | 63.04 | 187.26 |
Value | 327.46M | 135.94M |
Indicative Equilibrium Price | 63 | 188 |
Indicative Equilibrium Volume | 957 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Samcro Hyosung Adilestari Tbk.
PT Samcro Hyosung Adilestari Tbk (The Company) was established on Republic of Indonesia based on Deed of Establishment No. 265 dated July 21, 1989 by Yudo Paripurno, S.H., Notary in Jakarta.
Read more on ACRO →About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →
